Back to search

National and Kapodistrian University of Athens

Ο ρόλος του E2F1 στο λέμφωμα Hodgkin

Abstract

dc:description

Hodgkin’s lymphoma (HL) was first described by Sir Thomas Hodgkin in 1832, from which it took its name. It is considered up to now, in most cases, a B-cell lymphoma without excluding cases of T-cell origin. It constitutes 30% of all lymphomas. The basic diagnostic feature of HL is the presence of rare neoplastic multinucleated Reed-Sternberg and mononuclear Hodgkin cells (HRS cells) within an inflammatory reactive environment of T and B lymphocytes, admixed with plasma cells, macrophages, eosinophils, mast cells and fibroblasts. It seems that the microenvironment interacts with the tumor cells and somehow ensures their survival.The E2F-1 transcriptional factor is the first and best described member of the E2F family. It consists of an N terminal binding site of DNA and one C final position for binding “pocket” proteins. The E2F1 selectively binds to Retinoblastoma protein (pRb). This connection is the first and most important interaction between E2F factors and "pocket" proteins. E2F-1 appears on the G1-S phase of interphase. Molecules such as proteins ATM / ATR and chk2 directly phosphorylate E2F1 in Ser positions 31 and Ser 364 respectively during DNA repair process and thus E2F1 participates in the DNA damage response pathway (DDR).Its role is rather surprising, as it has been proven to promote proliferation or apoptosis in different tissues, events that are by nature opposed processes. The role of E2F1 in HL has not been elucidated and its effect on the development and course of this entity remains unknown.The purpose of our study was to examine the immunohistochemical expression of E2F-1 in HL and to correlate it with proliferation and apoptosis of the tumor, clinicopathological parameters and patient outcome, as well as with the expression of the downstream molecules p53 and p21.E2F-1 showed a median value of 80 %. A significant positive correlation was found between expression of E2F-1 and p53 (p= 0.034). Following stratification of our cases, within the group harboring functional p53, a statistically significant inverse correlation was identified between E2F-1 and Topo IIa (p= 0.019).E2F-1 is upregulated in the context of HL and its expression is inversely associated with proliferation. It seems that functional p53 can modulate the relationship between E2F-1 expression and tumor kinetics in HL. E2F-1 is likely capable of leading to apoptosis, acting thus as a tumor suppressor gene in HL.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Georgiadi, Eleni
  • Γεωργιάδη, Ελένη

Subjects

dc:subject × 11

Rights

dc:rights
Statement dc:rights
  • BY_NC_SA
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/35616

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Georgiadi, Eleni; Γεωργιάδη, Ελένη. Ο ρόλος του E2F1 στο λέμφωμα Hodgkin. National and Kapodistrian University of Athens, 2015. http://hdl.handle.net/10442/hedi/35616